Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial

Author： Krösser Sonja Neugebauer Roland Dolgos Hugues Fluck Markus Rost Karl-Ludwig Kovar Andreas

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.62, Iss.4, 2006-04, pp. : 277-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Chromatographic Determination of Drugs and Their Metabolites for Phenotyping Cytochrome P-450 Isoenzymes

By Ramenskaya G.

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 2, 2005-02 ,pp. : 108-111

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 and Anticancer Drugs

Current Drug Metabolism, Vol. 7, Iss. 1, 2006-01 ,pp. : 23-37

Bentham Science Publishers

Access to resources Recommend Favorite

The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics

By Daniel W.A. Syrek M. Haduch A.

European Neuropsychopharmacology, Vol. 12, Iss. 5, 2002-10 ,pp. : 371-377

Elsevier

Access to resources Recommend Favorite

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric Legendre Christopher Beaune Philippe Anglicheau Dany

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia Roots Ivar Goldammer Mark Rosenkranz Bernd

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite